Cargando…

Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease

Alzheimer’s disease (AD) still remains an enigma for researchers and clinicians. The onset of AD is insidious, gradually progressive and multifactorial. The recent accumulated scientific evidences suggests that the pathological changes resemble the autoimmune-driven self-sustaining inflammatory proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Talwar, Puneet, Kushwaha, Suman, Gupta, Renu, Agarwal, Rachna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838686/
https://www.ncbi.nlm.nih.gov/pubmed/31736740
http://dx.doi.org/10.3389/fnagi.2019.00290
_version_ 1783467270909984768
author Talwar, Puneet
Kushwaha, Suman
Gupta, Renu
Agarwal, Rachna
author_facet Talwar, Puneet
Kushwaha, Suman
Gupta, Renu
Agarwal, Rachna
author_sort Talwar, Puneet
collection PubMed
description Alzheimer’s disease (AD) still remains an enigma for researchers and clinicians. The onset of AD is insidious, gradually progressive and multifactorial. The recent accumulated scientific evidences suggests that the pathological changes resemble the autoimmune-driven self-sustaining inflammatory process as a result of prolonged oxidative stress and immune dyshomeostasis. Apart from aging, during life span various other factors—mainly environmental, lifestyle, chronic stress, polymicrobial infections and neuroendocrine functions—affect the immune system. Here, we provide crosstalk among “trigger insults/inflammatory stimulus” i.e., polymicrobial infection, chronic stress, pro-inflammatory diet and cholinergic signaling to put forward a “Systemic Immune Dyshomeostasis” model as to connect the events leading to AD development and progression. Our model implicates altered cholinergic signaling and suggests pathological stages with various modifiable risk factors and triggers at different chronological age and stage of cognitive decline. The search of specific autoantibodies for AD which may serve as the suitable blood/CSF biomarkers should be actively pursued for the early diagnosis of AD. The preventive and therapeutic strategies should be directed towards maintaining the normal functioning of the immune system throughout the life span and specific modulation of the immune responses in the brain depending on the stage of changes in brain.
format Online
Article
Text
id pubmed-6838686
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68386862019-11-15 Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease Talwar, Puneet Kushwaha, Suman Gupta, Renu Agarwal, Rachna Front Aging Neurosci Neuroscience Alzheimer’s disease (AD) still remains an enigma for researchers and clinicians. The onset of AD is insidious, gradually progressive and multifactorial. The recent accumulated scientific evidences suggests that the pathological changes resemble the autoimmune-driven self-sustaining inflammatory process as a result of prolonged oxidative stress and immune dyshomeostasis. Apart from aging, during life span various other factors—mainly environmental, lifestyle, chronic stress, polymicrobial infections and neuroendocrine functions—affect the immune system. Here, we provide crosstalk among “trigger insults/inflammatory stimulus” i.e., polymicrobial infection, chronic stress, pro-inflammatory diet and cholinergic signaling to put forward a “Systemic Immune Dyshomeostasis” model as to connect the events leading to AD development and progression. Our model implicates altered cholinergic signaling and suggests pathological stages with various modifiable risk factors and triggers at different chronological age and stage of cognitive decline. The search of specific autoantibodies for AD which may serve as the suitable blood/CSF biomarkers should be actively pursued for the early diagnosis of AD. The preventive and therapeutic strategies should be directed towards maintaining the normal functioning of the immune system throughout the life span and specific modulation of the immune responses in the brain depending on the stage of changes in brain. Frontiers Media S.A. 2019-10-23 /pmc/articles/PMC6838686/ /pubmed/31736740 http://dx.doi.org/10.3389/fnagi.2019.00290 Text en Copyright © 2019 Talwar, Kushwaha, Gupta and Agarwal. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Talwar, Puneet
Kushwaha, Suman
Gupta, Renu
Agarwal, Rachna
Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title_full Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title_fullStr Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title_full_unstemmed Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title_short Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease
title_sort systemic immune dyshomeostasis model and pathways in alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838686/
https://www.ncbi.nlm.nih.gov/pubmed/31736740
http://dx.doi.org/10.3389/fnagi.2019.00290
work_keys_str_mv AT talwarpuneet systemicimmunedyshomeostasismodelandpathwaysinalzheimersdisease
AT kushwahasuman systemicimmunedyshomeostasismodelandpathwaysinalzheimersdisease
AT guptarenu systemicimmunedyshomeostasismodelandpathwaysinalzheimersdisease
AT agarwalrachna systemicimmunedyshomeostasismodelandpathwaysinalzheimersdisease